Health

AstraZeneca heart drug Brilinta may find sailing tough

AstraZeneca heart drug Brilinta may find sailing tough

AstraZeneca heart drug Brilinta may find sailing tough

Many people will not believe this study as it is funded by the company. But other studies are going to throw more light on the genuineness of the claim. AstraZeneca has claimed that its drug Brilinta is very effective in treating long-Term DAPT.

AstraZeneca’s Brilinta is actually the most recent anti-clotting drug from the phama giant. A study conducted by the phama major has claimed that long-term use of the drug not just cuts possibility of heart attacks in heart attack survivors it also brings down the risk factor of stroke or heart-related death.

Though the latest study will be taken with a pinch of salt by the experts across the world as it was funded by AstraZeneca itself, nonetheless from the face value it looks very reliable.

Heart-attackDr. Marc Sabatine, a renowned cardiologist who is associated with Brigham and Women’s Hospital and Harvard Medical School in Boston actually led the study. Researchers tracked outcomes for 21,162 myocardial infarction patients across 31 countries with all of them having survived a heart attack in the previous one to three years.

The same group of people are said to be also suffering from either diabetes or older age thereby putting them at a greater risk for another heart attack and were taking aspirin as a preventive measure. Researchers claim that in the course of the study, patients were randomly given a twice-daily dose of either 90 milligrams (mg) of Brilinta (ticagrelor), 60 mg of the drug, or an inactive placebo. All of them continued to take the low-dose aspirin, ranging from 75 mg to 150 mg.

It is needless to say that researchers were very impressed with the findings of the study. Over an average follow-up of about 33 months, the researchers found that risk of heart attack, stroke and heart-related death was 15 per cent lower among those who took the 90-mg dose of Brilinta and 16 per cent lower among those who took the 60-mg dose of the drug, compared with those who took the placebo.

While talking about the development, a very excited Dr Sabatine said that notwithstanding the fact that both ticagrelor doses reduced ischemic events and cardiovascular death compared with placebo, the better choice was the 60-mg dose as it was better tolerated and the bleeding rate was less with it. “The benefit we saw [from Brilinta] was remarkably consistent across the individual components of [heart health events] and in all the major subgroups of patients,” he went on to add.

More in Health

  • Measures Taken by the Government to mainstream AYUSH System of medicine

    Measures Taken by the Government to mainstream AYUSH System of medicine NVONews Desk, New Delhi: The National Policy on Indian Systems of Medicine & Homoeopathy – 2002, envisages integration of AYUSH with the Health Care Delivery System. Mainstreaming of AYUSH is one of the strategies in National Health Mission (NHM) as well...

  • CSIR conducts research on benefits of medicines made from cow urine in chronic diseases

    CSIR conducts research on benefits of medicines made from cow urine in chronic diseases New Delhi: Council...

  • Prime Minister Modi lays foundation stone of newest AIIMS in Bathinda

    NVONews Desk, Bathinda: The Prime Minister, Shri Narendra Modi, today laid the Foundation Stone of the All India Institute of Medical Sciences (AIIMS) at Bathinda in Punjab. Speaking on the occasion, the Prime Minister said that social infrastructure is essential for the development of every nation, and therefore, we need top quality...

  • Vice President Ansari says neglect of healthcare will have negative impact on India’s economy

    Vice President Ansari says neglect of healthcare will have a negative impact on India’s economy New Delhi: The Vice President of India, M. Hamid Ansari has said that neglect of healthcare will have a negative impact on India’s economy combined with rising population. He was addressing on the occasion of 20th Anniversary...

  • Mass mobilization programmes for sanitation awareness taken up across the country

    Mass mobilization programmes for sanitation awareness taken up across the country New Delhi: Rallies, shramadan, village and ward level meetings were organized today in rural and urban areas across the county for further sensitizing the people about cleanliness on the first day of Swachh Bharat Week. Minister of Urban Development Shri M.Venkaiah...

  • MoU signed between CCRAS and University of Latvia

    MoU signed between Central Council for Research in Ayurvedic Sciences (CCRAS) and University of Latvia New Delhi: A Memorandum of Understanding (MOU) between the Central Council for Research in Ayurvedic Sciences (CCRAS) and University of Latvia on establishment of an academic chair in Ayurveda was signed today at AYUSH Bhawan, New Delhi....

  • JNMC organizes workshop on ‘Role of Ultrasonography in Regional Anaesthesia and Pain Management’

    JNMC organizes workshop on ‘Role of Ultrasonography in Regional Anaesthesia and Pain Management’ Aligarh: The Department of Anaesthesiology, Jawaharlal Nehru Medical College (JNMC) and ‘Critical Care’ today organised a day-long Symposium-cum-Workshop on the role of ‘Ultrasonography in Regional Anaesthesia and Pain Management’. Aligarh Muslim University Vice Chancellor, Lt General Zameer Uddin Shah...

  • Prof Anees carries out successful Whipple’s Procedure on four patients

    Prof Anees carries out successful Whipple’s Procedure on four patients Aligarh: The Department of Surgery, J N Medical College (JNMC), Aligarh Muslim University reached another milestone after four patients were treated with a successful Whipple’s Procedure done by Professor Afzal Anees and his team. The patients, who have recovered will soon be...